Helena’s high-quality factor deficient plasmas are trusted worldwide by pharmaceutical and government customers, offering a reliable method for the quality control of haemophilia treatment products.
Factor VIII and Factor IX Deficient Plasmas are widely used for the quality control of Haemophilia A and Haemophilia B treatment products. Our congenital plasmas are sourced from naturally-deficient human donors and do not suffer from the removal of other proteins which can occur with immunodepleted products.
Helena Biosciences offer a full range of Factor Deficient Plasmas in both congenital and immunodepleted formats, and our plasmas are available as guaranteed HIV and Hepatitis-negative.
The intrinsic factor deficient plasmas are intended for the quantitative determination of specific factor activity in citrated human plasma. This one-stage method requires an appropriate APTT reagent and any instrument capable of performing APTT-based factor assay testing.
Component |
REF |
Volume |
---|---|---|
Factor VIII Deficient Plasma (Congenital) |
5193 |
10 × 1 mL |
Factor VIII Deficient Plasma (Immunodepleted) |
5793 |
10 × 1 mL |
Component |
REF |
Volume |
---|---|---|
Factor IX Deficient Plasma (Congenital) |
5194 |
10 × 1 mL |
Factor IX Deficient Plasma (Immunodepleted) |
5794 |
10 × 1 mL |
Key: Liquid Lyophilised
Leave your details using this quick form and we will get in touch.